2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations - IBSLOR - Ingénierie, Biologie et Santé en Lorraine Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2020

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Eric Westhof
  • Fonction : Auteur
  • PersonId : 837072

Résumé

Nonsense mutations cause about 10% of genetic disease cases, and no treatments are available. Nonsense mutations can be corrected by molecules with nonsense mutation readthrough activity. An extract of the mushroom Lepista inversa has recently shown high-efficiency correction of UGA and UAA nonsense mutations. One active constituent of this extract is 2,6-diaminopurine (DAP). In Calu-6 cancer cells, in which TP53 gene has a UGA nonsense mutation, DAP treatment increases p53 level. It also decreases the growth of tumors arising from Calu-6 cells injected into immunodeficient nude mice. DAP acts by interfering with the activity of a tRNA-specific 2'-O-methyltransferase (FTSJ1) responsible for cytosine 34 modification in tRNATrp. Low-toxicity and high-efficiency UGA nonsense mutation correction make DAP a good candidate for the development of treatments for genetic diseases caused by nonsense mutations.
Fichier principal
Vignette du fichier
2-6-Diaminopurine_as_a_highly_potent_corrector_of_UGA.pdf (1.46 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02515244 , version 1 (24-03-2020)

Licence

Paternité

Identifiants

Citer

Carole Trzaska, Séverine Amand, Christine Bailly, Catherine Leroy, Virginie Marchand, et al.. 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. Nature Communications, 2020, 11 (1), pp.1509. ⟨10.1038/s41467-020-15140-z⟩. ⟨hal-02515244⟩
386 Consultations
227 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More